TheIndiaTime

Sale of medicine for respiratory illnesses rose between 2024 and 2025, RS told

2026-02-11 - 00:55

Sales of respiratory medicines surged from ₹17,199.40 crore in 2024 to ₹18,912.64 crore in 2025, highlighting increased demand linked to air pollution.

Share this post: